Homepage | Lupus Science & Medicine
A lupus journal publishing basic, clinical, translational and epidemiological studies on all aspects of lupus and related diseases. An official journal of Lupus Foundation of America.
Homepage | Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
Authors | Lupus Science & Medicine - Lupus Science & …
Lupus Science & Medicine® is a global, peer reviewed, open access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
About | Lupus Science & Medicine - Lupus Science & Medicine
Lupus Science & Medicine® is a global, peer reviewed, open access online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all …
Disease-modifying therapies in systemic lupus erythematosus for ...
May 21, 2024 · Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was ‘minimising disease activity with the fewest treatment-associated …
31 SLE-DAS | Lupus Science & Medicine
Sep 4, 2024 · The systemic lupus erythematosus Disease Activity Score (SLE-DAS) aims to provide a practical, accurate, and sensitive to change tool to measure the activity of SLE. 1 …
AskanasefiAD, etfial Lupus Science Medicine 202411:e001124 doi:101136lupus-2023-001124 1 Disease- modifying therapies in systemic lupus erythematosus for extrarenal manifestations …
Clinical trial outcomes for SLE: what we have and what we need
Feb 14, 2024 · The paradigm of drug approval in SLE currently relies on successful large phase III randomised controlled trials and a set of primary, secondary and additional end points. Taken …
Thanoua etΔal Lupus Science Medicine 216e365 doi11136lupus21365 1 Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures Aikaterini Thanou , …
Abstract - Lupus Science & Medicine
Dec 14, 2022 · Methods A phase 2, multicenter, randomized, placebo-controlled, double-blind, parallel-group study enrolling adults with active, autoantibody-positive SLE with an inadequate …